Accelerating Approval Across Europe: Our FAST EU Pilot Success Story

Published on: June 2026

Introduction

Driving clinical innovation across Europe requires more than compliance: it demands precision, speed, and seamless collaboration.

As part of the FAST‑EU Pilot phase, VCLS partnered with a client to guide their Phase IIb/III CTA submissions for a small molecule in cardiovascular indication, and further evaluation activities across 12 EU countries under EU CTR, culminating in approvals in all of them.

This success showcases how targeted regulatory expertise, applied at the right moments, can turn complexity into a clear path to approval.

Where VCLS Made the Difference

VCLS’s impact was focused where it matters most: submission readiness and evaluation success.

Strengthening Submission Readiness from Day One 🔍

Ahead of submission, VCLS conducted a high-level regulatory review of CTA packages to ensure that no critical elements were missing that could trigger validation issues or delays.
VCLS’s approach was pragmatic and impact-driven:

• Focused exclusively on essential documentation required for validation
• Identified potential gaps that could delay acceptance into evaluation
• Prioritized findings based on criticality and regulatory risk
• Provided clear, compelling justifications for each recommendation

By securing submission completeness upfront, VCLS helped safeguard timelines and avoid unnecessary setbacks during the validation phase.

Accelerating RFI Resolution with Hands-On Expertise ⚡

Regulatory success doesn’t stop at submission: it is defined during evaluation.

During the RFI phase, VCLS worked side-by-side with the client in face-to-face sessions to lead their responses across:

• Clinical
• Non-clinical
• CMC

VCLS’s teams:

• Translated complex regulatory questions into clear, actionable responses
• Ensured consistency and alignment across functions and countries
• Brought structure and clarity to multi-disciplinary RFI handling

This close collaboration enabled fast, confident responses, helping maintain momentum throughout the evaluation process.

The Outcome

• ✅ Approvals secured in all 12 EU countries
• ✅ Smooth validation phase with minimized delays
• ✅ Efficient handling of complex, multi-disciplinary RFIs

Why It Matters

In accelerated EU frameworks like FAST EU, success depends on two critical factors:

• Getting submission readiness right the first time
• Executing flawlessly during evaluation

This project demonstrates how a focused, risk-based regulatory review combined with hands-on evaluation guidance can significantly improve outcomes and accelerate approvals across multiple markets.

Ready to Accelerate Your EU Strategy?

Whether preparing for submission or navigating complex evaluation phases, VCLS helps you stay ahead of regulatory expectations where it matters most.

Let’s connect and move your next milestone forward, faster.